通过调节 Akt/mTOR/Gsk-3β/GATA4 信号通路,促进心脏缩
Guoyong Li1, Fengming Wu1, Fan Lei1
1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.
Journal of cellular and molecular medicine
|August 3, 2025
概括
通过激活Akt/mTOR通路,MARCH5蛋白促进心脏缩. 抑制MARCH5可能为心力衰竭和心脏缩提供一种新的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 心脏缩是心力衰竭的主要危险因素.
- 了解心脏缩背后的分子机制对于开发有效治疗方法至关重要.
研究的目的:
- 为了研究MARCH5在心脏缩中的作用.
- 探索MARCH5作为心脏缩和心力衰竭的潜在治疗点.
主要方法:
- 在心脏缩模型中评估MARCH5表达,使用免疫组织化学,西部斑块 (WB) 和RT-qPCR.
- 进行了体外和体内功能增加和丧失的实验,用于MARCH5.5.
- 利用WB,RT-qPCR,共免疫沉 (CoIP),免疫组织化学和免疫光来阐明分子机制.
主要成果:
- 3月5日表达在缩心肌中升高调节.
- 3月5日过度表达加剧了Ang II诱导的心脏缩,而敲击则对抗了这些效应.
- 3月5日异合的小鼠在横向大动脉收缩 (TAC) 后显示心脏缩减缓和功能改善.
- MARCH5与Akt直接相互作用,增强了Akt,mTOR和Gsk3β的酸化,导致GATA4表达增加和心脏缩恶化.
结论:
- MARCH5在病理性心脏缩中起着重要作用.
- 在MARCH5中,通过Akt/mTOR/Gsk-3β/GATA4通路调节心脏缩.
- 3月5日是治疗心脏缩和心力衰竭的潜在治疗点.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K


